• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[超短期大剂量地塞米松治疗颅脑创伤。一项多中心研究的理论依据与设计]

[Ultra-high, short-term dexamethasone therapy in craniocerebral trauma. Rationale and design of a multicenter study].

作者信息

Gaab M R, Dietz H

机构信息

Neurochirurgische Klinik, Medizinische Hochschule Hannover.

出版信息

Neurochirurgia (Stuttg). 1989 Jul;32(4):93-100. doi: 10.1055/s-2008-1054013.

DOI:10.1055/s-2008-1054013
PMID:2671769
Abstract

In spite of 20 years of discussion the value of corticosteroids in the therapy of head injury still remains controversial. Most animal experiments show an improvement of edema parameters with dexamethasone given immediately after trauma; pharmacological data suggest a further increased "ultrahigh" dosage compared to so-called "high" doses up to now. Simultaneously, the treatment duration might be reduced to 48-72 h after injury. The clinical studies available are not satisfying due to low numbers of patients, insufficient trauma classification and restriction to most severe brain injuries, and do not allow a definite answer. Little side effects and risks, however, were found with clinical steroid trials so far. We therefore perform a new multicenter trial with dexamethasone after head injury, whose design is presented: A sufficient number of patients (n greater than = 240) is recruited according to a priori defined criteria for statistical evaluation. Treatment starts with ultrahigh dosage of 500 mg dexamethasone (Fortecortin) initially not later than 3 h after injury, the treatment duration is limited to 51 h. The selection of patients is based on restrictive criteria of inclusion and exclusion, the age of patients ranges from 15 to 55 years. For maximal statistical separation and for reduction of disturbing factors the representativity of trauma patients is intentionally neglected.

摘要

尽管经过了20年的讨论,但皮质类固醇在治疗头部损伤中的价值仍然存在争议。大多数动物实验表明,创伤后立即给予地塞米松可改善水肿参数;药理学数据表明,与目前所谓的“高剂量”相比,“超高”剂量可进一步增加。同时,损伤后的治疗时间可缩短至48 - 72小时。现有的临床研究由于患者数量少、创伤分类不足以及仅限于最严重的脑损伤而不尽人意,无法给出明确答案。然而,到目前为止的临床类固醇试验发现副作用和风险很小。因此,我们进行了一项新的头部损伤后地塞米松多中心试验,其设计如下:根据事先定义的统计评估标准招募足够数量的患者(n≥240)。治疗从损伤后不迟于3小时开始给予500毫克地塞米松(氟替可的松)的超高剂量,治疗时间限制为51小时。患者的选择基于严格的纳入和排除标准,患者年龄在15至55岁之间。为了实现最大程度的统计区分并减少干扰因素,创伤患者的代表性被有意忽略。

相似文献

1
[Ultra-high, short-term dexamethasone therapy in craniocerebral trauma. Rationale and design of a multicenter study].[超短期大剂量地塞米松治疗颅脑创伤。一项多中心研究的理论依据与设计]
Neurochirurgia (Stuttg). 1989 Jul;32(4):93-100. doi: 10.1055/s-2008-1054013.
2
"Ultrahigh" dexamethasone in acute brain injury. Results from a prospective randomized double-blind multicenter trial (GUDHIS). German Ultrahigh Dexamethasone Head Injury Study Group.急性脑损伤中的“超高剂量”地塞米松。一项前瞻性随机双盲多中心试验(GUDHIS)的结果。德国超高剂量地塞米松脑损伤研究组
Zentralbl Neurochir. 1994;55(3):135-43.
3
[Dose- and time-dependent dexamethasone effects in cold lesion-induced brain edema in the rat. Experimental research accompanying the German Ultrahigh Dexamethasone Head Injury Study (GUDHIS)].[地塞米松对大鼠冷损伤诱导的脑水肿的剂量和时间依赖性效应。伴随德国超高剂量地塞米松颅脑损伤研究(GUDHIS)的实验研究]
Neurochirurgia (Stuttg). 1990 Jan;33(1):1-7. doi: 10.1055/s-2008-1053544.
4
Neuroprotective effect of gacyclidine. A multicenter double-blind pilot trial in patients with acute traumatic brain injury.加环利定的神经保护作用。一项针对急性创伤性脑损伤患者的多中心双盲试验。
Neurochirurgie. 2004 Jun;50(2-3 Pt 1):83-95.
5
[Treatment results in severe craniocerebral trauma with and without dexamethasone therapy].[地塞米松治疗与未治疗的严重颅脑创伤的治疗结果]
Neurochirurgia (Stuttg). 1985 Mar;28(2):46-50. doi: 10.1055/s-2008-1054182.
6
[Possibilities and limitations of intensive therapy in severe craniocerebral injuries].[重症颅脑损伤强化治疗的可能性与局限性]
Aktuelle Traumatol. 1983 Aug;13(4):139-44.
7
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.全身治疗失败后鼓室内注射地塞米松治疗突发性感音神经性听力损失
Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15.
8
Prognosis of severe head injuries in childhood and adolescence.儿童和青少年重度颅脑损伤的预后
Neuropediatrics. 1983 Aug;14(3):176-81. doi: 10.1055/s-2008-1059574.
9
Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
Jpn J Clin Oncol. 1986 Sep;16(3):279-87.
10
Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.一项关于通过圆窗导管持续鼓室内注射地塞米松治疗全身治疗失败后的重度至极重度特发性突发性感音神经性听力损失的安全性和有效性的随机、双盲、安慰剂对照试验。
Laryngoscope. 2009 Feb;119(2):359-69. doi: 10.1002/lary.20074.

引用本文的文献

1
Problems of the Glasgow Coma Scale with early intubated patients.格拉斯哥昏迷量表在早期插管患者中的问题。
Neurosurg Rev. 1995;18(4):253-7. doi: 10.1007/BF00383876.